# Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia

> **NCT00218231** · PHASE2 · COMPLETED · sponsor: **National Institute on Drug Abuse (NIDA)** · enrollment: 48 (actual)

## Conditions studied

- Schizophrenia
- Tobacco Use Disorder

## Interventions

- **DRUG:** 300 mg/day bupropion-sr
- **DRUG:** 0 mg/day bupropion-sr

## Key facts

- **NCT ID:** NCT00218231
- **Lead sponsor:** National Institute on Drug Abuse (NIDA)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2006-08
- **Final completion:** 2006-08
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00218231

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00218231, "Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT00218231. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*